These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7447426)

  • 1. Relative resistance to erythromycin in Chlamydia trachomatis.
    Mourad A; Sweet RL; Sugg N; Schachter J
    Antimicrob Agents Chemother; 1980 Nov; 18(5):696-8. PubMed ID: 7447426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics.
    Jones RB; Van der Pol B; Martin DH; Shepard MK
    J Infect Dis; 1990 Dec; 162(6):1309-15. PubMed ID: 2230260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
    Welsh LE; Gaydos CA; Quinn TC
    Antimicrob Agents Chemother; 1992 Feb; 36(2):291-4. PubMed ID: 1318677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Minimum inhibitory concentration and minimum bactericidal concentration of tetracycline and erythromycin in 35 recent Munich isolates of Chlamydia trachomatis].
    Korting HC; Hartinger A
    Hautarzt; 1988 Mar; 39(3):161-5. PubMed ID: 3378887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis.
    Walsh M; Kappus EW; Quinn TC
    Antimicrob Agents Chemother; 1987 May; 31(5):811-2. PubMed ID: 3038010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
    Samra Z; Rosenberg S; Soffer Y; Dan M
    Diagn Microbiol Infect Dis; 2001 Mar; 39(3):177-9. PubMed ID: 11337185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
    Miyashita N; Matsumoto A; Matsushima T
    Microbiol Immunol; 2000; 44(4):267-9. PubMed ID: 10832970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic susceptibility of Chlamydia trachomatis.
    Blackman HJ; Yoneda C; Dawson CR; Schachter J
    Antimicrob Agents Chemother; 1977 Dec; 12(6):673-7. PubMed ID: 931365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of fleroxacin against Chlamydia trachomatis.
    Steele-Mortimer O; Meier-Ewert H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():65-70. PubMed ID: 3144551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of rifamycins alone and in combination with other antibiotics against Chlamydia trachomatis.
    Jones RB; Ridgway GL; Boulding S; Hunley KL
    Rev Infect Dis; 1983; 5 Suppl 3():S556-61. PubMed ID: 6635445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis.
    Lefèvre JC; Escaffre MC; Courdil M; Lareng MB
    Pathol Biol (Paris); 1993 Apr; 41(4):313-5. PubMed ID: 8233628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of minimal inhibitory concentration (MIC) and minimal lethal concentration (MLC) values for tetracycline, monocycline, erythromycin and rokitamycin against eleven strains of Chlamydia trachomatis].
    Bianchi A; Scieux C; Robache S; Vassias I; Pérol Y
    Pathol Biol (Paris); 1991 May; 39(5):442-5. PubMed ID: 1881673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo.
    Johannisson G; Sernryd A; Lycke E
    Sex Transm Dis; 1979; 6(2):50-7. PubMed ID: 494040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia trachomatis: in vitro susceptibility to antibiotics singly and in combination.
    Christensen JJ; Holten-Andersen W; Nielsen PB
    Acta Pathol Microbiol Immunol Scand B; 1986 Oct; 94(5):329-32. PubMed ID: 3788573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis.
    Busolo F; Conventi L
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):407-10. PubMed ID: 3137045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibility study on urogenital Chlamydia trachomatis to 19 kinds of antibiotics].
    Bai H; Dong J; Ning B
    Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):11-4, 60. PubMed ID: 7600311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of 3-azinomethyl-rifamycin (SPA-S-565) against Chlamydia trachomatis.
    Zanetti S; Usai D; Nonis A; Fadda G
    J Antimicrob Chemother; 1996 Feb; 37(2):357-9. PubMed ID: 8707747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activity of roxithromycin against Chlamydia trachomatis.
    Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
    J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of clindamycin against strains of Chlamydia trachomatis, Mycoplasma hominis, and Ureaplasma urealyticum isolated from pregnant women.
    Harrison HR; Riggin RM; Alexander ER; Weinstein L
    Am J Obstet Gynecol; 1984 Jul; 149(5):477-80. PubMed ID: 6742014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation.
    Lee CK; Bowie WR; Alexander ER
    Antimicrob Agents Chemother; 1978 Mar; 13(3):441-5. PubMed ID: 162541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.